Business Description
Icecure Medical Ltd
ISIN : IL0011224156
Total Employee Number:
66Description
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 58.38 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -14.7 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -13.4 | |||||
3-Year EBITDA Growth Rate | 18.9 | |||||
3-Year EPS without NRI Growth Rate | 19 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -39 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 33.32 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 97.61 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 19.99 | |||||
9-Day RSI | 33.98 | |||||
14-Day RSI | 38.79 | |||||
3-1 Month Momentum % | -30.04 | |||||
6-1 Month Momentum % | -68.32 | |||||
12-1 Month Momentum % | -78.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.52 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 1.69 | |||||
Days Inventory | 398.47 | |||||
Days Sales Outstanding | 23.16 | |||||
Days Payable | 165.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.3 | |||||
Shareholder Yield % | -151.86 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.55 | |||||
Operating Margin % | -439.94 | |||||
Net Margin % | -441.6 | |||||
EBITDA Margin % | -432.23 | |||||
FCF Margin % | -417.62 | |||||
OCF Margin % | -415.34 | |||||
ROE % | -220.23 | |||||
ROA % | -123.07 | |||||
ROIC % | -268.27 | |||||
3-Year ROIIC % | 191.72 | |||||
ROC (Joel Greenblatt) % | -1141.32 | |||||
ROCE % | -218.13 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.99 | |||||
PB Ratio | 0.98 | |||||
Price-to-Tangible-Book | 0.98 | |||||
EV-to-EBIT | -0.16 | |||||
EV-to-EBITDA | -0.17 | |||||
EV-to-Revenue | 0.72 | |||||
EV-to-Forward-Revenue | 0.42 | |||||
EV-to-FCF | -0.17 | |||||
Price-to-GF-Value | 0.15 | |||||
| Price-to-Net-Current-Asset-Value | 1.14 | |||||
| Price-to-Net-Cash | 2.52 | |||||
Earnings Yield (Greenblatt) % | -625 | |||||
FCF Yield % | -141.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ICCM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Icecure Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.565 | ||
| EPS (TTM) ($) | -7.2 | ||
| Beta | 0.9449 | ||
| 3-Year Sharpe Ratio | -0.52 | ||
| 3-Year Sortino Ratio | -0.69 | ||
| Volatility % | 58.27 | ||
| 14-Day RSI | 38.79 | ||
| 14-Day ATR ($) | 0.66431 | ||
| 20-Day SMA ($) | 4.273 | ||
| 12-1 Month Momentum % | -78.97 | ||
| 52-Week Range ($) | 2.12 - 42 | ||
| Shares Outstanding (Mil) | 3.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Icecure Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Icecure Medical Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-19 10:00 | In 119 days | ||
| Third quarter earnings results for 2026 | 2026-11-19 | In 118 days | ||
| General meeting for 2025 | 2026-08-20 18:30 | In 28 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 11:00 | In 21 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 20 days | ||
| Special General Meeting of Shareholders | 2026-08-06 15:00 | In 14 days | ||
| 0.0333333:1 Stock Split | 2026-06-04 | 4.55 (+16.69%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 11:00 | 7.20 (-2.83%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 7.20 (-2.83%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-17 11:00 | 21.90 (+7.96%) |
Show
Entries
Icecure Medical Ltd Frequently Asked Questions
What is Icecure Medical Ltd(ICCM)'s stock price today?
The current price of ICCM is $3.08. The 52 week high of ICCM is $42.00 and 52 week low is $2.12.
When is next earnings date of Icecure Medical Ltd(ICCM)?
The next earnings date of Icecure Medical Ltd(ICCM) is 2026-08-13 Est..
Does Icecure Medical Ltd(ICCM) pay dividends? If so, how much?
Icecure Medical Ltd(ICCM) does not pay dividend.
Guru Commentaries on NAS:ICCM
No articles.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers